Improving hygiene standards is important to patient safety. What better way to learn more about considerations for improving hygiene standards, than from first hand experiences from medical professionals? Research shows that to create and maintain an endoscopes’ disinfected status, complete drying is an absolute necessity. Flexible endoscopes should be completely dried after completion of the…
A promising approach to treating cancer—called targeted alpha-particle therapy or TAT—could better harness the curative power of radiation treatments and lessen the severity of their more debilitating side effects.
A recent preclinical study from scientists at Sunnybrook Research Institute, Canadian Blood Services and the University of Toronto has demonstrated that focused ultrasound improves the delivery of intravenous immunoglobulin (IVIg), a blood product composed of antibodies from healthy donors, previously shown to have potential in treating a subgroup of patients with Alzheimer’s disease.
Electrophysiologists in Europe will now have access to state-of-the-art, gold-tipped force sensing ablation catheters following the Biotronik announcement that AlCath Force is CE-market approved. With the release of the unique catheter, a full suite of specialized tools for a complete solution in the treatment of complex atrial fibrillation (AF) cases is available to physicians.
Researchers in Finland have developed a machine learning model that can help us treat cancer more effectively.
In April 2017, St. Marien Hospital in Siegen, Germany, made robotic history: it was the first hospital in Germany to introduce the Transenterix surgical robotic system. Since then, more than 450 surgeries were performed with the Senhance® surgical robotic system and the expertise of Professor Dr Dietmar Stephan, Head of Minimally Invasive Surgery, is in high demand – worldwide.
In a preclinical study, NIH scientists found that the commonly used antibiotic methacycline may be effective at combating the neurological problems caused by Zika virus infections.
"Molecular glue degraders" are a new class of cancer drugs, which "glue" cancer growth-promoting proteins directly to the molecular machinery of a cell's disposal system, leading to the subsequent degradation of the cancer-driving proteins and anti-tumor activity. Scientists from Heidelberg and USA have now deciphered another mechanism whereby a small molecule can degrade a…
As a world leading manufacturer of medical devices, the subclassification of Contec Medical products includes numerous series for multi-parameter monitoring, ECG, oximeter, blood pressure, telemedicine health, respiratory sleep, and more. With the frequently increasing occurrence of respiratory diseases, Contec Medical reports on its great efforts in the research and development of related…
Researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer.
You don’t need to stand up to stand out. A few decades ago, a little boy believed he could tend to patients in spite of being in a wheelchair – and he did. During the EANS 2020 virtual meeting, Prof. Dr. Thomas Kapapa explained how he breaks barriers and helps promote diversity every day in his clinical practice in Germany and Malawi.
Among refurbishments at seven operating theatres at Marien Hospital in Hamburg, Germany, are new PCs and wall-mounted monitors supplied by the Mönchengladbach-based medical IT manufacturer and developer of software and hardware Rein Medical GmbH. ‘It was important to find a supplier which specialised in hardware for the operating theatre and who could supply high-quality products,’ said Rolf…
How extraordinary it is that the 200th anniversary of the birth of Florence Nightingale, the founder of modern nursing, is celebrated on the year of the outbreak of the COVID-19 pandemic. Her key nursing values – including regularly washing hands and maintaining good hygiene – and her pioneering work in statistics and data collection have proven more relevant than ever.
Safety and protection for patients and healthcare professionals during routine procedures is imperative for Fujifilm, which it intends to pursue by constantly innovating its offering of accessories and instruments for endoscopy. The company announced the launch of the Mouthpiece “B1” incorporating a sponge rubber, a droplet reduction accessory, and a drape shield specifically created to catch…
Increasingly, hospitals use 3D printing in surgery because the technology can enable fast, unique production of patient-tailored tools at relatively low costs. ‘As the technology itself is developing and accelerating at a fast pace, hospitals may be left behind if they choose not to adopt these advances,’ said Limor Haviv, surgical 3D printing designer at 3D4OP. Today, 3D printing is used in…
University of Pittsburgh School of Medicine scientists have discovered the fastest way to identify potent, neutralizing human monoclonal antibodies against SARS-CoV-2, the virus that causes COVID-19.
The Focused Ultrasound Foundation (FUS) has published its 2020 State of the Field Report, a 63-page annual update detailing new potential indications, laboratory research, clinical trials, treatments and growth in worldwide procedures performed in 2019.
Over-activity in a single brain region called the subgenual anterior cingulate cortex (sgACC) underlies several key symptoms of mood and anxiety disorders, but an antidepressant only successfully treats some of the symptoms. A new study suggests that sgACC is a crucial region in depression and anxiety, and targeted treatment based on a patient's symptoms could lead to better outcomes.
Leukemia frequently originates from the so-called leukemic stem cell, which resides in a tumor promoting and protecting niche within the bone marrow. Scientists from the Max Planck Institute of Biochemistry in Martinsried, Germany, have found a new way to make these cells vulnerable by specifically dislodging these cells from their niches.
Chemistry researchers at the University of Strathclyde are aiming to raise awareness of pancreatic cancer – with the use of specially-made quilts. Fellow cancer researchers across the UK are being asked to send diagrams illustrating their work. These will then be used as the patterns for quilts made by skilled crafters. After the project is concluded, the Strathclyde researchers hope to be able…
Convalescent plasma shows limited effectiveness as a potential treatment for patients with COVID-19 to help them fight off the infection, finds a clinical trial from India published by The BMJ. The findings show that convalescent plasma fails to reduce mortality or stop progression to severe COVID-19.
Vaccines are being hailed as the solution to the COVID-19 pandemic, but the vaccine trials currently underway are not designed to tell us if they will save lives, reports Peter Doshi, Associate Editor at The BMJ. Several COVID-19 vaccine trials are now in their most advanced (phase 3) stage, but what will it mean exactly when a vaccine is declared “effective”? Many may assume that successful…
The professional perception of vitamin D as a medicine, rather than as a key nutrient, is constraining practice and jeopardising the health of elderly care home residents in England, conclude researchers in the journal BMJ Nutrition Prevention & Health. At a time when the vulnerability of elderly care home residents is under the spotlight because of the impact of COVID-19, an urgent review is…
The COVID-19 pandemic has impacted virtually every aspect of cancer care and research– from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of cancer research.
Setting up ‘COVID-19 free’ hospital areas for surgical patients could save lives during the second wave of the pandemic – reducing the risk of death from lung infections associated with coronavirus, a new global study reveals. Researchers working together in Brazil and beyond found that that patients who had their operation and hospital care in ‘COVID-19 free’ areas had better outcomes.…